Follistatin Gene Therapy for sIBM and Becker Muscular...
Transcript of Follistatin Gene Therapy for sIBM and Becker Muscular...
![Page 1: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/1.jpg)
Follistatin Gene Therapy for
sIBM and Becker Muscular Dystrophy
Jerry R Mendell, MD Research Institute at Nationwide Children’s
Hospital
![Page 2: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/2.jpg)
The Clinical Problem • Quadriceps muscle weakness
– Becker muscular dystrophy – Inclusion body myositis
• Frequent falls – Limb fractures – Loss of ambulation
• Improving quadriceps muscle strength would result in a
“clinically meaningful outcome”
![Page 3: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/3.jpg)
Resistant to Approaches
• Weight training
• Electrical Stimulation
• Anabolic Steroids
![Page 4: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/4.jpg)
Myostatin Circulates Propeptide Complex Activated
Protease Cleavage
Activin Receptor
M M
M M
MYOSTATIN REGULATION OF MUSCLE SIZE
INHIBIT BINDING Gene mutation
Antibody Peptides
Myostatin Regulates Muscle Growth
![Page 5: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/5.jpg)
Myostatin Gene Mutation
• Targeted disruption of the myostatin gene: increases muscle size and body weight
- “Mighty” Mouse (Mstn KO) - Double-muscled cow (Mstn Het)
- Newborn with gene mutation mutation N Engl J Med. 2004;350:2682-8
McPherron et al 1997
![Page 6: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/6.jpg)
Wyeth sponsored 11 Center Trial (10 USA;1GB) Using antibody to myostatin
• No Clinical benefit • High dose cohorts developed skin hypersensitivity reactions
Ann Neurology March 11, 2008
![Page 7: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/7.jpg)
Circulating complex Propeptide-myostatin M M
Propeptide cleavage
M M
FOLLISTATIN
Activin Receptor
AAV-FOLLISTATIN
Follistatin Gene Therapy
INJECT AAV INTO MUSCLE
![Page 8: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/8.jpg)
Follistatin Gene 1 2 3 4 5 6a 6b
1 2 3 4 5 1 2 3 4 5 6b
1) Alternative Splicing
Pre-FS317 Pre-FS344 2) Translation
N Domain FS Domain I FS Domain II FS Domain III N Domain FS Domain I FS Domain II FS Domain III C
3) Cleavage of Signal Peptide (29aa)
FS 288 FS 315 Circulating isoform Tissue bound isoform
SP SP
N Domain FS Domain I FS Domain II FS Domain III N Domain FS Domain I FS Domain II FS Domain III C
![Page 9: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/9.jpg)
Treatment of mdx with AAV1.FS344
Q and TA Bilateral
1e11
1e10
![Page 10: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/10.jpg)
Tibialis Anterior
5 mo post gene transfer
> 1year>
![Page 11: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/11.jpg)
CK
Hind
Limb
Grip S
tren
gth
3 months post gene transfer
![Page 12: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/12.jpg)
Moving to Non-Human Primates to Simulate Clinical Trial
Can the Mouse Studies Predict Safety and Efficacy in a Clinical
Trial ?
![Page 13: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/13.jpg)
FS344 Gene Transfer to Monkey
![Page 14: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/14.jpg)
AAV1-FS
Control
5 MO POST GENE TRANSFER
![Page 15: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/15.jpg)
Functional Improvement Promoter
Twitch Force Tetanic Force
Untreated Leg
FS-Treated
Untreated leg
FS-Treated
MCK 17.0 19.0 (11.8%) 65.0 73.0 (12.3%)
CMV 19.0 24.0 (26.3%) 64.0 72.0 (12.5%)
![Page 16: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/16.jpg)
No Cardiotoxicity** 5 and 15 months
Study Training - 15March2012
![Page 17: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/17.jpg)
Clinical Chemistries Monkeys used in Pre-clinical Studies
![Page 18: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/18.jpg)
Necropsies of NHP used in Pre-Clinical Studies
• Full necropsy on all monkeys – slides on each organ evaluated by a board
certified veterinary pathologist blinded to treatment group (control vs FS)
• No treatment-related abnormalities found in heart, liver, lung, spleen, kidney, testis, ovary and uterus (5 &15 months)
![Page 19: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/19.jpg)
Taking this to Clinical Trial
Prepare for Clinical Trial Develop Outcome Measures
![Page 20: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/20.jpg)
![Page 21: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/21.jpg)
r = 0.578 p < 0.001
r=0.603 p < 0.001
![Page 22: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/22.jpg)
AAV1.CMV.Follistatin IND
09-12-11
8 in
Final Step Before Clinical Trial Submit the IND
![Page 23: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/23.jpg)
AAV1.Follistatin Clinical Trial
• 18 subjects (9 sIBM /9 Becker muscular dystrophy patients)
• Dose escalation study injection of AAV1.CMV.FS344 into quadriceps
• Outcome: 6MWT and Quantitative myometry of Knee extensors
• Muscle biopsies at 3 months and 6 months • Patients will be followed for 2 years
![Page 24: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/24.jpg)
Circumventing Barriers to Negative Gene Therapy Trial
• Avoid pre-existing immunity to AAV – Some individuals have been exposed to virus
and should be excluded from the trial • Avoid immune immune response to
follistatin – Less likely but possible and patients should
be checked
![Page 25: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/25.jpg)
Hopefully Making Progress For Challenging Conditions !
Three Patients have been treated to date and no adverse events encountered
![Page 26: Follistatin Gene Therapy for sIBM and Becker Muscular ...videos.parentprojectmd.org/conference12/PDF/Mendell_Follistatin.pdfFollistatin Gene Therapy for sIBM and Becker Muscular Dystrophy](https://reader035.fdocuments.us/reader035/viewer/2022071210/602123e905f32f614a10e186/html5/thumbnails/26.jpg)
SUCCESS IS A TEAM EFFORT ! Center at
Nationwide Children’s Hospital Cellular Immune Christopher Walker Katie Campbell Gene Therapy Center Brian Kaspar PRE-CLINCAL EFFORTS K Reed Clark VECTOR MANUFACTURING Chris Shilling PROGRAM MANAGER Xiomara Rosales FDA LIAISON